Nonalcoholic steatohepatitis (NASH) is a well‐recognized cause of cirrhosis and has been
increasingly associated with the development of hepatocellular carcinoma (HCC). The aims …

On the basis of phylogenetic analysis of nucleotide sequences, multiple genotypes and
subtypes of hepatitis C virus (HCV) have been identified. Characterization of these genetic …

In patients with nonalcoholic fatty liver disease (NAFLD), a liver biopsy remains the only
reliable way to differentiate simple steatosis from nonalcoholic steatohepatitis (NASH). …

Liver biopsy remains the gold standard for diagnosing nonalcoholic steatohepatitis (NASH).
We have recently demonstrated that plasma cytokeratin 18 (CK‐18) fragment levels …

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D) are
growing public health problems, and are strongly associated. The link between the two …

Objective: To study 1) the geographic distribution and clinical significance of hepatitis C virus
[HCV] genotypes in the United States and 2) the influence of HCV genotypes on response …

The growing demand for liver transplantation and the concomitant scarcity of cadaveric livers
have increased the need for living donor liver transplantation (LDLT). Ensuring the safety of …

Eosinophilic esophagitis (EE) is a newly described inflammatory lesion characterized by dense
eosinophilic infiltration of the esophagus that occurs in the absence of gastroesophageal …

Nonalcoholic fatty liver disease (NAFLD) is a chronic disease with a histological spectrum
ranging from steatosis alone, to nonalcoholic steatohepatitis (NASH). The latter is associated …

Background Nonalcoholic steatohepatitis ( NASH ), the most severe form of nonalcoholic
fatty liver disease ( NAFLD ), is associated with inflammation and increased oxidative stress. …